Ablation rates and long term outcome following low dose radioiodine for differentiated thyroid cancer in the West of Scotland: a retrospective analysis
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists(2024)
摘要
•Low dose radioiodine is effective in low to intermediate risk DTC•Remnant ablation rate is >90% based on HiLo criteria•Locoregional recurrence rate is <2% after median follow up of over 8 years
更多查看译文
关键词
Differentiated thyroid cancer,low dose radioiodine,remnant ablation,recurrence
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要